CRP and COVID-19: The median baseline blood biomarkers; were significantly higher in the ‘COVID-19 pneumonia’ group compared to the ‘mild COVID-19’ group: Neutrophil/Lymphocyte ratio (4.4 VS 1.9; P <0.0001), CRP (21.6 VS 3.9; P <0.0001), D dimer (452.5 VS 301; P = 0.0005) and LDH (676 VS 481; P <0.0001).